Clinician's Roundtable

As President Barack Obama travels the country talking about the need for health care reform, hardly a week goes by when you don't hear the Commander in Chief talk about Intermountain Healthcare and its low costs when compared to the rest of the country. What makes this this large healthcare system an example? Nancy Nowak, vice president of clinical operations and chief nursing officer for Intermountain Healthcare in Salt Lake City, Utah, tells host Bruce Japsen about this much talked-about healthcare system and how its work may be replicated across the country.

As President Barack Obama travels the country talking about the need for health care reform, hardly a week goes by when you don't hear the Commander in Chief talk about Intermountain Healthcare and its low costs when compared to the rest of the country. What makes this this large healthcare system an example? Nancy Nowak, vice president of clinical operations and chief nursing officer for Intermountain Healthcare in Salt Lake City, Utah, tells host Bruce Japsen about this much talked-about healthcare system and how its work may be replicated across the country.

Mucopolysaccharidosis I, or MPS I, often presents initially as a child's failure to thrive, and is a diagnosis with devastating effects. How is new research able to help children with this lysosomal storage disorder? Host Dr. Bruce Bloom talks with Dr. David A. Pearce, director of the Sanford Children's Health Research Center in Sioux Falls, South Dakota, about advances in research into treatment options, including enzyme replacement therapy, for MPS I.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations

Immune System Irregularities in Lysosomal Storage Disorders

Long Term Efficacy and Safety of Laronidase for MPS I

Mucopolysaccharidosis I, or MPS I, often presents initially as a child's failure to thrive, and is a diagnosis with devastating effects. How is new research able to help children with this lysosomal storage disorder? Host Dr. Bruce Bloom talks with Dr. David A. Pearce, director of the Sanford Children's Health Research Center in Sioux Falls, South Dakota, about advances in research into treatment options, including enzyme replacement therapy, for MPS I.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations

Immune System Irregularities in Lysosomal Storage Disorders

Long Term Efficacy and Safety of Laronidase for MPS I

How is the immune system involved in lysosomal storage disorders, including juvenile Batten disease, Niemann-Pick type C disease and Krabbe disease? Host Dr. Bruce Bloom welcomes Dr. David A. Pearce, director of the Sanford Children's Health Research Center in Sioux Falls, South Dakota, to discuss research into the immune response in these patients.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Challenges in Management of MPS I

Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations

Long Term Efficacy and Safety of Laronidase for MPS I

How is the immune system involved in lysosomal storage disorders, including juvenile Batten disease, Niemann-Pick type C disease and Krabbe disease? Host Dr. Bruce Bloom welcomes Dr. David A. Pearce, director of the Sanford Children's Health Research Center in Sioux Falls, South Dakota, to discuss research into the immune response in these patients.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Challenges in Management of MPS I

Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations

Long Term Efficacy and Safety of Laronidase for MPS I

What are the musculoskeletal signs and symptoms in children with MPS I? How can we test for MPS I? And how does the disease present in patients as they grow up? Dr. Gregory M. Pastores, associate professor of neurology and pediatrics at the New York University School of Medicine in New York, and director of the neurogenetics laboratory in the department of neurology at NYU, explores with host Dr. Bruce Bloom the diagnostic challenges and management considerations to be reviewed when treating MPS I patients.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Challenges in Management of MPS I

Immune System Irregularities in Lysosomal Storage Disorders

Long Term Efficacy and Safety of Laronidase for MPS I

What are the musculoskeletal signs and symptoms in children with MPS I? How can we test for MPS I? And how does the disease present in patients as they grow up? Dr. Gregory M. Pastores, associate professor of neurology and pediatrics at the New York University School of Medicine in New York, and director of the neurogenetics laboratory in the department of neurology at NYU, explores with host Dr. Bruce Bloom the diagnostic challenges and management considerations to be reviewed when treating MPS I patients.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Challenges in Management of MPS I

Immune System Irregularities in Lysosomal Storage Disorders

Long Term Efficacy and Safety of Laronidase for MPS I

Host Dr. Bruce Bloom welcomes Dr. Emil Kakkis, an advisor at BioMarin Pharmaceutical Inc. and author of numerous published articles on mucopolysaccharidosis I, or MPS I, to discuss current treatment options. They discuss the benefits and risks of enzyme replacement therapy with laronidase.

Don't miss these other programs on MPS I, with host Dr. Bruce Bloom:

Challenges in Management of MPS I

Immune System Irregularities in Lysosomal Storage Disorders

Musculoskeletal Aspects of MPS I: Diagnosis and Management Considerations

If you've been following the health care reform debate as closely as we have, you may be suffering from a case of whiplash, with so many proposals and so little time to wade through all the back-and forth on each of them. As Congress heads into its customary August recess, we'll take a step back to examine the issues that could make or break the various proposals for overhauling our health care system. For one perspective on the progress toward reform, host Dr. Michael Greenberg welcomes American Medical Association (AMA) President Dr. James Rohack. Dr. Rohack addresses a range of issues, including the nuances of AMA's recent support for House bill HR 3200, the effectiveness of AMA in representing the interests of all physicians in this reform debate, and the prospects for true medical liability protections in the final reform bill.